These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


314 related items for PubMed ID: 9952307

  • 1. Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors.
    Little MP, Boice JD.
    Radiat Res; 1999 Feb; 151(2):218-24. PubMed ID: 9952307
    [Abstract] [Full Text] [Related]

  • 2. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study.
    Howe GR, McLaughlin J.
    Radiat Res; 1996 Jun; 145(6):694-707. PubMed ID: 8643829
    [Abstract] [Full Text] [Related]

  • 3. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP.
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cancer risks and biomarker studies in the atomic bomb survivors.
    Preston D.
    Stem Cells; 1995 May; 13 Suppl 1():40-8. PubMed ID: 7488967
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Male Breast Cancer Incidence and Mortality Risk in the Japanese Atomic Bomb Survivors - Differences in Excess Relative and Absolute Risk from Female Breast Cancer.
    Little MP, McElvenny DM.
    Environ Health Perspect; 2017 Feb; 125(2):223-229. PubMed ID: 27286002
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
    Little MP.
    Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
    [Abstract] [Full Text] [Related]

  • 11. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT, Cologne JB, Moriwaki H, Vaeth M, Mabuchi K.
    Prev Med; 1997 Apr; 26(1):144-53. PubMed ID: 9010910
    [Abstract] [Full Text] [Related]

  • 12. Risk of breast cancer following low-dose radiation exposure.
    Boice JD, Land CE, Shore RE, Norman JE, Tokunaga M.
    Radiology; 1979 Jun; 131(3):589-97. PubMed ID: 441361
    [Abstract] [Full Text] [Related]

  • 13. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP.
    Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Does fractionation decrease the risk of breast cancer induced by low-LET radiation?
    Brenner DJ.
    Radiat Res; 1999 Feb; 151(2):225-9. PubMed ID: 9952308
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis.
    Kai M, Luebeck EG, Moolgavkar SH.
    Radiat Res; 1997 Oct; 148(4):348-58. PubMed ID: 9339951
    [Abstract] [Full Text] [Related]

  • 20. Timing of menarche and first birth in relation to risk of breast cancer in A-bomb survivors.
    McDougall JA, Sakata R, Sugiyama H, Grant E, Davis S, Nishi N, Soda M, Shimizu Y, Tatsukawa Y, Kasagi F, Suyama A, Ross P, Kopecky KJ, Li CI.
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1746-54. PubMed ID: 20570914
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.